Bright Minds Biosciences Inc. (DRUG)
USD 38.03
(-4.33%)
USD 38.03
(-4.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 72.45 Thousand | 6037.00 | - | - | - |
| Gross Profit | -72.45 Thousand | -6037.00 | - | - | - |
| Operating Expenses | 7.21 Million | 14.73 Million | 8.6 Million | 469.35 Thousand | 78.71 Thousand |
| Selling, General and Administrative Expenses | 2.19 Million | 2.55 Million | 2.29 Million | 114.5 Thousand | 36.7 Thousand |
| Research and Development Expenses | 4.99 Million | 12.18 Million | 6.31 Million | 354.85 Thousand | 42 Thousand |
| Other Expenses | - | -243.07 Thousand | -181.74 Thousand | -5451.00 | - |
| Cost and Expenses | 7.21 Million | 14.73 Million | 8.6 Million | 469.35 Thousand | 78.71 Thousand |
| Operating Income | -7.21 Million | -14.74 Million | -8.75 Million | -469.35 Thousand | -78.72 Thousand |
| Interest Expense | 19.75 Thousand | 222.77 Thousand | - | - | - |
| Income Tax Expense | - | 222.77 Thousand | -135.43 Thousand | 5568.00 | -236.15 |
| Earnings before Tax | -7.37 Million | -14.96 Million | -8.65 Million | -480.37 Thousand | -78.71 Thousand |
| Net Income | -7.37 Million | -15.18 Million | -8.51 Million | -485.94 Thousand | -78.71 Thousand |
| Earnings Per Share Basic | -1.98 | -6.15 | -4.74 | -0.38 | -0.06 |
| Earnings Per Share Diluted | -1.98 | -6.15 | -4.74 | -0.38 | -0.06 |
| Weighted Average Shares Outstanding | 3.71 Million | 2.47 Million | 1.79 Million | 1.28 Million | 1.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.71 Million | 2.47 Million | 1.79 Million | 1.28 Million | 1.28 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -7.32 Million | -14.73 Million | - | - | - |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 18.11 Thousand | 18.11 Thousand | 18.11 Thousand | 18.11 Thousand | 72.45 Thousand | 18.11 Thousand |
| Gross Profit | -18.11 Thousand | -18.11 Thousand | -18.11 Thousand | -18.11 Thousand | -72.45 Thousand | -18.11 Thousand |
| Operating Expenses | -254.09 Thousand | 537.82 Thousand | 1.67 Million | 1.58 Million | 7.38 Million | 1.43 Million |
| Selling, General and Administrative Expenses | 312.65 Thousand | 432.64 Thousand | 452.39 Thousand | 459.16 Thousand | - | 380.32 Thousand |
| Research and Development Expenses | -566.74 Thousand | 105.18 Thousand | 1.22 Million | 1.09 Million | - | 1.05 Million |
| Other Expenses | 11.36 Thousand | - | - | - | - | -17.18 Thousand |
| Cost and Expenses | -235.98 Thousand | 555.93 Thousand | 1.69 Million | 1.58 Million | 7.38 Million | 1.43 Million |
| Operating Income | 235.98 Thousand | -555.94 Thousand | -1.69 Million | -1.64 Million | -7.4 Million | -1.42 Million |
| Interest Expense | 1241.00 | 2126.00 | 2971.00 | 3786.00 | 19.75 Thousand | 4576.00 |
| Income Tax Expense | -4.00 | -2.00 | -3.00 | -57.93 Thousand | -14.18 Thousand | 10.1 Thousand |
| Earnings before Tax | 229.9 Thousand | -574.14 Thousand | -1.68 Million | -1.52 Million | -7.37 Million | -1.45 Million |
| Net Income | 229.9 Thousand | -574.14 Thousand | -1.68 Million | -1.52 Million | -7.37 Million | -1.45 Million |
| Earnings Per Share Basic | 0.05 | -0.13 | -0.44 | -0.41 | - | -0.39 |
| Earnings Per Share Diluted | 0.05 | -0.13 | -0.44 | -0.41 | - | -0.39 |
| Weighted Average Shares Outstanding | 4.46 Million | 4.46 Million | 3.84 Million | 3.77 Million | 3.71 Million | 3.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.64 Million | 4.46 Million | 3.84 Million | 3.77 Million | 3.71 Million | 3.77 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | 254.08 Thousand | -537.83 Thousand | -1.67 Million | -1.62 Million | - | -1.4 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
HAIN
3090
8377
BSX
VSTTILLERS
TRIP